IndraLab

Statements

Tanespimycin inhibits RIPK1. 2 / 2

| 2

➶

reach

"A reduction in the cellular levels of RIP1 was also observed in those cell lines treated with 17AAG."

19632771

➶

reach

"In both H23 and HepG2 cells, the Hsp90 inhibitor 17AAG caused dramatic degradation of RIP1 and IKKbeta, two critical components for TNF-alpha-induced NF-kappaB activation, regardless of the presence of SMC3."

20862547

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Tanespimycin inhibits RIPK1. 2 / 2

INDRA sources:

Databases

Reading